You've stayed active through menopause. Will you be sidelined by its symptoms?

We are conducting a clinical research study to test the safety and efficacy

of an investigational drug in preventing postmenopausal osteoporosis and treating

menopausal symptoms while ensuring endometrial (uterine lining) safety.

You may be able to participate if you:

• are currently 40 to 64 years old

• have had your last menstrual cycle less than five years ago

• are menopausal and experiencing menopausal symptoms

• have not had a hysterectomy

• have not used oral hormonal treatments such as estrogen, progestin, androgen- or SERM-containing products within the past two months.

Study participation lasts for approximately 14 1/2 months. Participants can expect up to eight visits to the study doctor. Qualified participants may receive study-related office visits, medical evaluations, mammograms, gynecological exams, bone density scans if eligible and the study drug at no cost.

To listen to an audio presentation about this study, please click here.

For more information about this study, please contact Ridgeview Research at (952) 556-2687.